Imaging lung lymphocytic infiltration with radiolabelled Interleukin-2 in the follow-up of patients with lung transplantation; a marker of acute rejection

Imaging lung lymphocytic infiltration with radiolabelled Interleukin-2 in the follow-up of patients with lung transplantation; a marker of acute rejection - 99mTc-IL2 for imaging lymphocytic infiltration after lung transplantation

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33003

Enrollment

Registered

2009-12-15

Start date

2009-11-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute rejection lung transplantation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patient with lung transplantation

Exclusion criteria

Exclusion criteria: Children, pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Evalution of IL-2 scan to detect acute rejection. Comparison between IL-2 uptake and histopathological findings.	—

Secondary

Measure	Time frame
Nvt	—

Countries

Netherlands

Outcome results